Patent directory · USPTO A61K / A61P
Patents matching “laquinimod”
18 pharma patents match "laquinimod" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 18 pharmaceutical patents matching "laquinimod" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9662322
Laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS) patients with a high disability status
granted -
US 9585878
Treatment of BDNF-related disorders using laquinimod
granted -
US 9340307
Stable laquinimod preparations
granted -
US 9233927
Crystals of laquinimod sodium and improved process for the manufacture thereof
granted -
US 9161935
Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF therapy
granted -
US 9161936
Laquinimod for treatment of GABA mediated disorders
granted -
US 8975279
Amine salts of laquinimod
granted -
US 8889627
Treatment of multiple sclerosis with combination of laquinimod and fingolimod
granted -
US 8889661
Treatment of lupus nephritis using laquinimod
granted -
US 8673322
Crystals of laquinimod sodium, and process for the manufacture thereof
granted -
US 8647646
Crystals of laquinimod sodium, and process for the manufacture thereof
granted -
US 8598203
Treatment of Crohn's disease with laquinimod
granted -
US 8545885
Stable laquinimod preparations
granted -
US 8501766
Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
granted -
US 8383645
Stable laquinimod preparations
granted -
US 8178127
Stable laquinimod preparations
granted -
US 7989473
Stable laquinimod preparations
granted -
US 7884208
Crystals of laquinimod sodium, and process for the manufacture thereof
granted